Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity

Chonbuk National University

Status

Completed

Conditions

Immunity

Treatments

Dietary Supplement: Cauliflower Mushroom extract

Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01736787

HANABIO-PI-CM

Details and patient eligibility

About

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cauliflower Mushroom extract on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-10, IFN- γ, TNF-α), and CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT), and monitored their blood pressure.

Enrollment

60 patients

Sex

All

Ages

30 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Males and females 30-65 years old
Weight within ±30% of ideal body weight
Able to give informed consent

Exclusion criteria

WBC concentration below 3000 ㎕
Allergic or hypersensitive to any of the ingredients in the test products
Diagnosed of gastrointestinal disease such as Immune-related diseases, severe hepatic, renal failure, and diabetes
History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
History of alcohol or substance abuse
Participation in any other clinical trials within past 2 months
Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Pregnant or lactating women etc.